Terumo Azur CX 35 Instructions For Use Manual


Azur CX 35 Peripheral Coil System
(Detachable)
Instructions for Use

DEVICE DESCRIPTION

The Detachable Azur CX 35 Peripheral Coil System (Azur
system) consists of a coil implant attached to a delivery system.
The coils are platinum-based coils with an inner layer of
hydrophilic polymer. The delivery pusher is powered by an Azur
Detachment Controller to selectively detach the coils. The Azur
Detachment Controller is provided separately.
The Azur system is available in a broad range of coil diameters
and lengths. The AZUR Detachable 35 coil must be delivered
through a double-braid reinforced catheter with the inner diameter
specified.
Table 1
Catheter I.D.
Coil Type
inches
AZUR Detachable 35 0.041- 0.047

INDICATIONS FOR USE

The Azur system is intended to reduce or block the rate of blood
flow in vessels of the peripheral vasculature. It is intended for use
in the interventional radiologic management of arteriovenous
malformations, arteriovenous fistulae, aneurysms, and other
lesions of the peripheral vasculature.
This device should only be used by physicians who have
undergone training in the use of the Azur system for embolization
procedures as prescribed by a representative from Terumo or a
Terumo-authorized distributor.
CONTRAINDICATIONS
Use of the Azur system is contraindicated in any of the following
circumstances:

When superselective coil placement is not possible.

When end arteries lead directly to nerves.

When arteries supplying the lesion to be treated are not
large enough to accept emboli.

When the A-V shunt is larger than the coil.

In the presence of severe atheromatous disease.

In the presence of vasospasm (or likely onset of
vasospasm).
POTENTIAL COMPLICATIONS
Potential complications include, but are not limited to: hematoma
at the site of entry, vessel/aneurysm perforation, unintended
parent artery occlusion, incomplete filling, vascular thrombosis,
hemorrhage, ischemia, vasospasm, edema, coil migration or
misplacement, premature or difficult coil detachment, clot
formation, revascularization, post-embolization syndrome, and
neurological deficits including stroke and possibly death.
The physician should be aware of these complications and
instruct patients when indicated. Appropriate patient
management should be considered.
Reposition
Time
mm
1.04 – 1.19 20 minutes
- 1 -

REQUIRED ADDITIONAL ITEMS


Azur Detachment Controller

Appropriately sized catheter with double-braid support for
delivery of the AZUR system

Guidewires compatible with catheter

Rotating hemostatic Y valves (RHV)

Three-way stopcocks

Pressurized sterile saline drip

One-way stopcock

Stopwatch or timer

WARNINGS AND PRECAUTIONS

Caution: Federal law (USA) restricts this device to sale by or
on the order of a physician.

The Azur system is supplied sterile and non-pyrogenic
unless package is opened or damaged.

This device is intended for single use only. Do not reuse,
reprocess or resterilize. Reuse, reprocessing or
resterilization may compromise the structural integrity of the
device and/or lead to device failure which, in turn, may result
in patient injury, illness, or death. Reuse, reprocessing, or
resterilization may also create a risk of contamination of the
device and/or cause patient infection or cross-infection,
including, but not limited to, the transmission of infectious
disease(s) from one patient to another. Contamination of the
device may lead to injury, illness or death of the patient.

Angiography is required for pre-embolization evaluation,
operative control, and post-embolization follow up.

Do not advance the delivery pusher with excessive force.
Determine the cause of any unusual resistance, remove the
Azur system, and check for damage.

Advance and retract the Azur system slowly and smoothly.
Remove the entire Azur system if excessive friction is noted.
If excessive friction is noted with a second Azur system,
check the catheter for damage or kinking.

The coil must be properly positioned in the vessel or
aneurysm within the specified reposition time from the time
the device is first introduced into the catheter. If the coil
cannot be positioned and detached within this time,
simultaneously remove the device and the catheter.
Positioning the device in a low-flow environment may
increase the reposition time.

If repositioning is necessary, take special care to retract the
coil under fluoroscopy in a one-to-one motion with the
delivery pusher. If the coil does not move in a one-to-one
motion with the delivery pusher, or if repositioning is difficult,
the coil may have become stretched and could possibly
break. Gently remove and discard the entire device.

Due to the delicate nature of the coils, the tortuous vascular
pathways that lead to certain lesions, and the varying
morphologies of the vasculature, a coil may occasionally
stretch while being maneuvered. Stretching is a precursor to
potential coil breakage and migration.

If a coil must be retrieved from the vasculature after
detachment, do not attempt to withdraw the coil with a
retrieval device, such as a snare, into the delivery catheter.
This could damage the coil and result in device separation.
Remove the coil, catheter, and any retrieval device from the
vasculature simultaneously.

Delivery of multiple coils is usually required to achieve the
desired occlusion of some vasculatures or lesions. The
desired procedural endpoint is usually angiographic
occlusion. The filling properties of the coils facilitate
angiographic occlusion.

Tortuosity or complex vessel anatomy may affect accurate
placement of the coil.

The long-term effect of this product on extravascular tissues
has not been established so care should be taken to retain
this device in the intravascular space.
PM-00861